
Sign up to save your podcasts
Or


In this episode, Chris, co-founder of Bio Box, delves into the innovative solutions his company offers to the biopharma sector. Bio Box provides a knowledge and reasoning infrastructure for biopharma R&D, helping scientists scale up hypothesis generation and testing in early drug discovery. Chris explains how their platform integrates various biomedical data sources to enable quicker, data-driven decisions and improve collaboration across research teams. He also discusses the challenges and rewards of building a startup in the biotech industry, particularly in the Canadian context, and shares insights on the importance of productive science and reasoning in drug discovery. Furthermore, Chris provides a glimpse into Bio Box's customer engagement strategies, business model, and his vision for the future of the company. Whether you are a scientist, investor, or just curious about the intersection of biotech and AI, this episode offers valuable insights into the evolving landscape of biopharma research.
By Amiral Ventures5
11 ratings
In this episode, Chris, co-founder of Bio Box, delves into the innovative solutions his company offers to the biopharma sector. Bio Box provides a knowledge and reasoning infrastructure for biopharma R&D, helping scientists scale up hypothesis generation and testing in early drug discovery. Chris explains how their platform integrates various biomedical data sources to enable quicker, data-driven decisions and improve collaboration across research teams. He also discusses the challenges and rewards of building a startup in the biotech industry, particularly in the Canadian context, and shares insights on the importance of productive science and reasoning in drug discovery. Furthermore, Chris provides a glimpse into Bio Box's customer engagement strategies, business model, and his vision for the future of the company. Whether you are a scientist, investor, or just curious about the intersection of biotech and AI, this episode offers valuable insights into the evolving landscape of biopharma research.

30,652 Listeners